AtriCure (ATRC) Research & Development (2016 - 2025)
Historic Research & Development for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $22.9 million.
- AtriCure's Research & Development rose 921.76% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.7 million, marking a year-over-year increase of 3370.52%. This contributed to the annual value of $96.2 million for FY2024, which is 3011.97% up from last year.
- Latest data reveals that AtriCure reported Research & Development of $22.9 million as of Q3 2025, which was up 921.76% from $29.3 million recorded in Q2 2025.
- AtriCure's Research & Development's 5-year high stood at $35.0 million during Q4 2024, with a 5-year trough of $11.2 million in Q1 2021.
- In the last 5 years, AtriCure's Research & Development had a median value of $17.4 million in 2023 and averaged $18.5 million.
- As far as peak fluctuations go, AtriCure's Research & Development tumbled by 319.32% in 2021, and later soared by 6809.48% in 2024.
- AtriCure's Research & Development (Quarter) stood at $13.8 million in 2021, then fell by 0.43% to $13.7 million in 2022, then surged by 51.27% to $20.8 million in 2023, then soared by 68.09% to $35.0 million in 2024, then tumbled by 34.51% to $22.9 million in 2025.
- Its last three reported values are $22.9 million in Q3 2025, $29.3 million for Q2 2025, and $22.5 million during Q1 2025.